A new breast cancer drug trialled at the Christie Hospital in Manchester could offer a lineline for women with the most aggressive form of the disease.
The drug, known as T-DM1, has been shown to increase the survival time of some patients by almost six months.
It also reduced side effects such as hair loss and gives sufferers a better quality of life.
More top news
A Barrow man has been sentenced to four years in prison for the manslaughter of his 13-year-old son Kye Backhouse.
The jury hearing the fresh Hillsborough inquests has adjourned for the summer with a warning from the Coroner to not look up anything on it.
The Manchester Fashion Industry show returns with a blue hues theme for this season's networking event.